financetom
Business
financetom
/
Business
/
Top Premarket Gainers
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Top Premarket Gainers
Jul 14, 2025 5:05 AM

07:30 AM EDT, 07/14/2025 (MT Newswires) -- Sonnet Biotherapeutics ( SONN ) shares were up nearly 287% pre-bell Monday after the company said it has agreed to merge with Rorschach, backed by Atlas Merchant Capital and Paradigm Operations and will build a reserve of HYPE, the token of the Hyperliquid Layer-1 blockchain.

Presidio Property Trust ( SQFT ) shares were 211% higher following a muted last session.

BIT Mining ( BTCM ) shares were up 33% after the company said it has completed the second phase of its acquisition of crypto mining data centers and Bitcoin mining machines in Ethiopia.

Thumzup Media ( TZUP ) stock was 9.8% higher after an 8.9% loss in the previous session.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Meta shares hit record high after US appeals court upholds TikTok ban
Meta shares hit record high after US appeals court upholds TikTok ban
Dec 6, 2024
NEW YORK (Reuters) - Shares of Facebook-owner Meta Platforms ( META ) hit a record high on Friday after a U.S. appeals court upheld a law requiring China-based ByteDance to divest its popular short video app TikTok by early next year or face a ban. The decision is a devastating blow to ByteDance, whose social media app is used by...
RBC Reviews TD's Q4, Cuts Target to $77
RBC Reviews TD's Q4, Cuts Target to $77
Dec 6, 2024
01:18 PM EST, 12/06/2024 (MT Newswires) -- TD is undergoing a strategic review which is a significant opportunity for the bank to reevaluate its whole strategy given the constraints under which it must now operate, writes RBC. Target has been trimmed to $77. RBC expects costs to remain elevated through the forecast period. Analyst Darko Mihelic is modelling ~1% core...
Stoke Therapeutics Reports Durable Seizure Control With Zorevunersen in Dravet Patient
Stoke Therapeutics Reports Durable Seizure Control With Zorevunersen in Dravet Patient
Dec 6, 2024
01:06 PM EST, 12/06/2024 (MT Newswires) -- Stoke Therapeutics ( STOK ) on Friday released data from Phase 1/2a and open-label extension studies of zorevunersen for the treatment of Dravet syndrome. The data analyzed nine patients who initially received two or three doses of 70 mg, followed by 45 mg maintenance dosing. Patients experienced substantial and sustained reductions in convulsive...
Nicolet Bankshares Insider Sold Shares Worth $1,010,785, According to a Recent SEC Filing
Nicolet Bankshares Insider Sold Shares Worth $1,010,785, According to a Recent SEC Filing
Dec 6, 2024
01:10 PM EST, 12/06/2024 (MT Newswires) -- Robert Bruce Atwell, Director, on December 05, 2024, sold 8,945 shares in Nicolet Bankshares ( NIC ) for $1,010,785. Following the Form 4 filing with the SEC, Atwell has control over a total of 33,249 shares of the company, with 32,831 shares held directly and 418 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1174850/000112760224028759/xslF345X05/form4.xml Price: 111.72,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved